CELL CANCER, SQUAMOUS

Clinical trials for CELL CANCER, SQUAMOUS explained in plain language.

Never miss a new study

Get alerted when new CELL CANCER, SQUAMOUS trials appear

Sign up with your email to follow new studies for CELL CANCER, SQUAMOUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New immune drug shows promise in early cancer trial

Disease control Completed

This early-phase trial tested a drug called MEDI0562, which aims to boost the immune system's ability to fight cancer. It was given to 13 patients with advanced head and neck cancer or melanoma before their surgery. The main goal was to see if the drug safely activates the immune…

Matched conditions: CELL CANCER, SQUAMOUS

Phase: PHASE1 • Sponsor: Providence Health & Services • Aim: Disease control

Last updated May 26, 2026 12:02 UTC

CELL CANCER, SQUAMOUS

Get alerted when new CELL CANCER, SQUAMOUS trials appear

New immune drug shows promise in early cancer trial